Quitting smoking isn’t just a matter of willpower. For long-time smokers—those who’ve made cigarettes part of their routine ...

Armed with an asset that could be an improvement on Pfizer’s blockbuster smoking cessation drug Chantix/Champix (varenicline) ...

Researchers used the drug Varenicline to block the pleasant effects of nicotine on the brains of a group of 16- to 25-year-olds over a 24-week period. Skip to main content ABC News ...

By Dr. Paul Racicot. A proposal by Washington lawmakers to impose new taxes on tobacco-free nicotine products would endanger some of the state’s most at-risk individuals and hurt broader public ...

Roughly half of US adult smokers try to quit each year but usually less than 10% succeed — mostly due to troubles managing intense cravings and withdrawal symptoms. A new treatment may help.

Not too long ago, vaping was seen as something that could help you quit smoking. Now, people are looking for a way to quit vaping. To the rescue comes ...

With $35 million in funding, Qnovia hopes its device will become the first new prescription nicotine replacement therapy in 20 years. Six years ago, in a townhouse in Santa Monica, Mario Danek ...

The tiny battery-powered devices that produce a mist of nicotine when you inhale, first popularized by Juul, are not outright banned—at least not for adults—but only a few flavored vapes have ...

WASHINGTON — Of the roughly 15 million Americans who tried to quit smoking in 2022, 5 in 6 failed.It’s a jarring statistic — and an indictment of the treatment options for an addiction that ...

Chantix is a prescription drug that can help people quit smoking tobacco. Medicare’s prescription drug plans include coverage for certain smoking cessation drugs, including Chantix. People 65 ...

Chantix is a prescription drug that can help people quit smoking tobacco. Medicare’s prescription drug plans include coverage for certain smoking cessation drugs, including Chantix. People 65 ...

In individuals with moderate to heavy dependence on nicotine, confirmed 7-day abstinence from smoking at week 26 -- the trial's primary endpoint -- was observed in 40.4% of the participants ...